These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 12560899)

  • 41. Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy.
    Gudbjartsson T; Gyllstedt E; Pikwer A; Jönsson P
    Ann Thorac Surg; 2008 Aug; 86(2):376-82. PubMed ID: 18640300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer.
    Ross P; Grecula J; Bekaii-Saab T; Villalona-Calero M; Otterson G; Magro C
    Lasers Surg Med; 2006 Dec; 38(10):881-9. PubMed ID: 17115382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
    Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
    J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature.
    Alam N; Shepherd FA; Winton T; Graham B; Johnson D; Livingston R; Rigas J; Whitehead M; Ding K; Seymour L
    Lung Cancer; 2005 Mar; 47(3):385-94. PubMed ID: 15713522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Atypical lung cancer resection? A clinical observation pro and contra].
    Weber J
    Zentralbl Chir; 1990; 115(1):35-42. PubMed ID: 2156393
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Compliance with adjuvant chemotherapy in non-small cell lung cancer. The experience of a single institution evaluating a cohort of 356 patients.
    Dediu M; Alexandru A; Median D; Anghel R; Tarlea A; Iorga P; Movanu M
    J BUON; 2006; 11(4):425-32. PubMed ID: 17309173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction chemotherapy does not increase the operative risk of pneumonectomy!
    Mansour Z; Kochetkova EA; Ducrocq X; Vasilescu MD; Maxant G; Buggenhout A; Wihlm JM; Massard G
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):181-5. PubMed ID: 17141515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bronchoplastic lobectomy: do early results depend on the underlying pathology? A comparison between typical carcinoids and primary lung cancer.
    Lemaitre J; Mansour Z; Kochetkova EA; Koriche C; Ducrocq X; Wihlm JM; Quoix E; Massard G
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):168-71. PubMed ID: 16723250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.
    Bauman JE; Mulligan MS; Martins RG; Kurland BF; Eaton KD; Wood DE
    Ann Thorac Surg; 2008 Nov; 86(5):1632-8; discussion 1638-9. PubMed ID: 19049763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
    Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac comorbidity is not a risk factor for mortality and morbidity following surgery for primary non-small cell lung cancer.
    Mishra PK; Pandey R; Shackcloth MJ; McShane J; Grayson AD; Carr MH; Page RD
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):439-43. PubMed ID: 19081729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
    Allen AM; Mentzer SJ; Yeap BY; Soto R; Baldini EH; Rabin MS; Sugarbaker DJ; Bueno R
    Cancer; 2008 Mar; 112(5):1106-13. PubMed ID: 18286507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Video-assisted thoracic surgery pulmonary resection for lung cancer in patients with poor lung function.
    Garzon JC; Ng CS; Sihoe AD; Manlulu AV; Wong RH; Lee TW; Yim AP
    Ann Thorac Surg; 2006 Jun; 81(6):1996-2003. PubMed ID: 16731119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.
    Petersen RP; Pham D; Burfeind WR; Hanish SI; Toloza EM; Harpole DH; D'Amico TA
    Ann Thorac Surg; 2007 Apr; 83(4):1245-9; discussion 1250. PubMed ID: 17383320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits.
    Doddoli C; Barlesi F; Trousse D; Robitail S; Yena S; Astoul P; Giudicelli R; Fuentes P; Thomas P
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):416-25. PubMed ID: 16077407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival.
    Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer.
    Takeda S; Maeda H; Okada T; Yamaguchi T; Nakagawa M; Yokota S; Sawabata N; Ohta M
    Eur J Cardiothorac Surg; 2006 Jul; 30(1):184-9. PubMed ID: 16730452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.